Live Breaking News & Updates on Viamet Pharmaceuticals Holdings
Stay updated with breaking news from Viamet pharmaceuticals holdings. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation. PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights March 15, 2021 GMT MALVERN, Pa. & SAN DIEGO (BUSINESS WIRE) Mar 15, 2021 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today reported financial results for the fourth-quarter and full-year ended December 31, 2020 and provided an update on clinical trial activities. ADVERTISEMENT “Throughout 2020, PhaseBio made significant progress advancing our pipeline of therapies for serious cardiopulmonary diseases,” said Jonathan P. Mow, Chief Executive Officer of PhaseBio Pharmaceuticals. “Our progress was driven by the continued global expansion of the pivotal Phase 3 REVERSE-IT trial of our lead product candidate bentracimab, whi ....
Come and apply the insights recommended by the honchos of the Candidiasis Therapeutics industry.
Candidiasis Therapeutics Market Report, published by Decisive Markets Insights, provides granular information & analysis on the size, share, growth patterns, segment and forecast of the market from, 2020 – 2027.The report covers the rapidly evolving market scenario and the current and future evaluation of their impact on the overall industry along with regional coverage across the globe. With an in-depth report on sales growth and profitability, it also covers the accurate trend and analysis that would impact the market in the coming years. The analysis provides key players, a competitive perspective so as to formulate their business strategies accordingly. ....